Clearmind Medicine Inc (CMND)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 10/31
| 07-2023 | 04-2023 | 01-2023 | 12-2022 | 10-2022 | |
| Cash Flows From Operating Activities | |||||
| Net Income | -4,551 | -3,976 | -1,900 | N/A | -7,310 |
| Depreciation Amortization | 18 | 9 | 5 | 24 | 24 |
| Other Working Capital | -1,354 | -913 | -1,513 | 1,311 | 1,311 |
| Other Operating Activity | 338 | 708 | 305 | 2,026 | 2,026 |
| Operating Cash Flow | $-5,548 | $-4,173 | $-3,103 | $3,361 | $-3,949 |
| Cash Flows From Investing Activities | |||||
| PPE Investments | N/A | N/A | N/A | -6 | -6 |
| Other Investing Activity | 8 | 0 | 0 | 0 | 0 |
| Investing Cash Flow | $8 | $N/A | $N/A | $-6 | $-6 |
| Cash Flows From Financing Activities | |||||
| Common Stock Issued | 9,300 | 9,322 | 6,364 | N/A | 583 |
| Other Financing Activity | -41 | -31 | -16 | -60 | -40 |
| Financing Cash Flow | $9,259 | $9,291 | $6,348 | $-60 | $543 |
| Exchange Rate Effect | 0 | -1 | -4 | N/A | -24 |
| Beginning Cash Position | 129 | 129 | 129 | N/A | 3,573 |
| End Cash Position | 3,847 | 5,246 | 3,369 | N/A | 137 |
| Net Cash Flow | $3,719 | $5,117 | $3,241 | $3,295 | $-3,436 |
| Free Cash Flow | |||||
| Operating Cash Flow | -5,548 | -4,173 | -3,103 | 3,361 | -3,949 |
| Capital Expenditure | N/A | N/A | N/A | N/A | -6 |
| Free Cash Flow | -5,548 | -4,173 | -3,103 | 3,361 | -3,955 |